Catalent provides fill/finish services in a range of formats to support clinical and commercial products.
From sites in the US and Europe, Catalent provides drug product development and manufacturing services, leveraging proven expertise from preclinical phase to commercial launch, to supply small molecules, biologics, vaccines, and biosimilars. Catalent has extensive experience with drug product process development across a variety of liquid and lyophilized formulations into vials, syringes and cartridges. Its facilities and high-speed filling lines offer aseptic processing that is flexible, fast, and integrated with secondary packaging.